PureTech Health PLC (PRTC)

Currency in USD
16.75
-0.62(-3.57%)
Closed·
PRTC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.7517.85
52 wk Range
13.3020.00
Key Statistics
Prev. Close
17.37
Open
17.85
Day's Range
16.75-17.85
52 wk Range
13.3-20
Volume
2.53K
Average Volume (3m)
2.86K
1-Year Change
-15.91%
Book Value / Share
1.56
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRTC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
46.00
Upside
+174.63%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

PureTech Health PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. The company also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development; oral therapies based on defined bacterial consortia that is in phase 3 clinical stage; and engineering hematopoietic stem cells to enable targeted therapies for patients with blood cancers. Further, it develops voice-based technology platform that detects changes in the sound of voice that are linked with health conditions, including depression, anxiety, and respiratory disease. The company was incorporated in 2015 and is based in Boston, Massachusetts.

Compare PRTC to Peers and Sector

Metrics to compare
PRTC
Peers
Sector
Relationship
P/E Ratio
7.8x−2.6x−0.6x
PEG Ratio
0.050.050.00
Price/Book
1.0x4.6x2.6x
Price / LTM Sales
61.7x12.1x3.2x
Upside (Analyst Target)
178.8%39.5%41.8%
Fair Value Upside
Unlock2.1%5.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 46.00
(+174.63% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Dec 03, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

59.48
HBCP
-0.42%
5.140
CMPX
0.00%

FAQ

What Is the PureTech Health (PRTC) Share Price Today?

The live PureTech Health share price today is 16.75

What Stock Exchange Does PureTech Health (PRTC) Trade On?

PureTech Health is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for PureTech Health?

The stock symbol (also called a 'ticker') for PureTech Health is "PRTC."

What Is the Current PureTech Health Market Cap?

As of today, PureTech Health market capitalisation is 415.20M.

What Is PureTech Health's (PRTC) Earnings Per Share (TTM)?

The PureTech Health EPS is currently 0.20 (Trailing Twelve Months).

When Is the Next PureTech Health Earnings Date?

PureTech Health's next earnings report will be released on 03 Dec 2025.

Is PRTC a Buy or Sell From a Technical Analyst Perspective?

Based on today's PureTech Health moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has PureTech Health Stock Split?

PureTech Health has split 0 times. (See the PRTC stock split history page for full effective split date and price information.)

How Many Employees Does PureTech Health Have?

PureTech Health has 56 employees.

What is the current trading status of PureTech Health (PRTC)?

As of 24 Dec 2025, PureTech Health (PRTC) is trading at a price of 16.75, with a previous close of 17.37. The stock has fluctuated within a day range of 16.75 to 17.85, while its 52-week range spans from 13.30 to 20.00.

What Is PureTech Health (PRTC) Price Target According to Analysts?

The average 12-month price target for PureTech Health is USD46, with a high estimate of USD46 and a low estimate of USD46. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +174.63% Upside potential.

What Is the PRTC After Hours Price?

PRTC's last after hours stock price is 16.78, the stock has decreased by -0.25, or -1.47%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.